|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Receivables, net (less allowance for credit loss of $3,338 and $1,190 at September 30, 2026, and December 31, 2025, respectively) | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Refundable income taxes | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant, and equipment | ||||||||||||||||||||
| Less accumulated depreciation and amortization | ||||||||||||||||||||
| Property, plant, and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Investment in joint venture | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Current maturities of long-term debt | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Contingent consideration | ||||||||||||||||||||
| Federal and state excise taxes payable | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Accrued expenses and other | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, less current maturities | ||||||||||||||||||||
| Convertible senior notes | ||||||||||||||||||||
| Long-term operating lease liabilities | ||||||||||||||||||||
| Contingent consideration | ||||||||||||||||||||
| Other noncurrent liabilities | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||||
| Capital stock | ||||||||||||||||||||
| Preferred, 5% non-cumulative; $10 par value; authorized 1,000 shares; issued and outstanding 437 shares | ||||||||||||||||||||
| Common stock | ||||||||||||||||||||
| No par value; authorized 40,000,000 shares; issued 23,125,166 shares at September 30, 2026 and December 31, 2025; and 21,418,944 and 21,294,315 shares outstanding at September 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Treasury stock, at cost, 1,706,222 and 1,830,851 shares at September 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Total MGP Ingredients, Inc. stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
| Common stock, issued (in shares) | ||||||||||||||||||||
Loading...
